We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$256M
AUM Growth
+$21.5M
Cap. Flow
-$11.9M
Cap. Flow %
-4.66%
Top 10 Hldgs %
33.39%
Holding
180
New
20
Increased
24
Reduced
108
Closed
11

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.77M
2
RTX icon
RTX Corp
RTX
+$1.52M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.37M
4
AAPL icon
Apple
AAPL
+$1M
5
AGN
Allergan plc
AGN
+$793K

Sector Composition

Rank Sector Weight
1 Healthcare 22.17%
2 Technology 15.02%
3 Financials 9.38%
4 Industrials 8.86%
5 Consumer Staples 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEF icon
26
Sprott Physical Gold and Silver Trust
CEF
$7.39B
$2.58M 1.01%
152,942
-97
-0.1% -$1.54K
PG icon
27
Procter & Gamble
PG
$335B
$2.55M 1%
21,302
-3,552
-14% -$414K
EXPD icon
28
Expeditors International
EXPD
$22.1B
$2.5M 0.98%
32,886
-481
-1% -$35.1K
BRK.A icon
29
Berkshire Hathaway Class A
BRK.A
$1.1T
$2.4M 0.94%
9
AMGN icon
30
Amgen
AMGN
$207B
$2.36M 0.93%
10,027
-66
-0.7% -$15.1K
NSC icon
31
Norfolk Southern
NSC
$75.5B
$2.32M 0.91%
13,206
-142
-1% -$24.1K
SBUX icon
32
Starbucks
SBUX
$120B
$2.25M 0.88%
30,606
-2,650
-8% -$199K
WMT icon
33
Walmart Inc
WMT
$886B
$2.15M 0.84%
53,808
-5,280
-9% -$217K
LIN icon
34
Linde
LIN
$221B
$2.11M 0.83%
9,958
-455
-4% -$87.9K
DGX icon
35
Quest Diagnostics
DGX
$25.9B
$2.07M 0.81%
18,131
-1,022
-5% -$108K
DIS icon
36
Walt Disney
DIS
$167B
$1.96M 0.77%
17,599
-539
-3% -$59.5K
VIG icon
37
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.93M 0.75%
16,444
-354
-2% -$40.3K
GIS icon
38
General Mills
GIS
$19.3B
$1.88M 0.74%
30,565
-1,655
-5% -$99.8K
CHRW icon
39
C.H. Robinson
CHRW
$17.8B
$1.82M 0.71%
23,035
-1,325
-5% -$100K
UNP icon
40
Union Pacific
UNP
$174B
$1.77M 0.69%
10,475
-2,458
-19% -$394K
VMBS icon
41
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$1.76M 0.69%
32,395
-1,150
-3% -$62.6K
VWO icon
42
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$1.76M 0.69%
44,401
-5,704
-11% -$211K
BDX icon
43
Becton Dickinson
BDX
$45.3B
$1.73M 0.68%
7,418
+79
+1% +$19K
CNC icon
44
Centene
CNC
$30.7B
$1.73M 0.68%
27,152
-290
-1% -$18.9K
MTB icon
45
M&T Bank
MTB
$35.9B
$1.66M 0.65%
16,007
-77
-0.5% -$8.13K
PYPL icon
46
PayPal
PYPL
$48.7B
$1.63M 0.64%
9,338
-1,292
-12% -$179K
NVS icon
47
Novartis
NVS
$298B
$1.51M 0.59%
17,257
-500
-3% -$43.2K
ETR icon
48
Entergy
ETR
$50.7B
$1.5M 0.59%
32,046
-300
-0.9% -$14.6K
BIIB icon
49
Biogen
BIIB
$30.3B
$1.45M 0.57%
5,437
-24
-0.4% -$7.21K
BND icon
50
Vanguard Total Bond Market
BND
$157B
$1.41M 0.55%
15,967
+2,340
+17% +$205K

Similar funds

Roberts, Glore & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Roberts, Glore & Co held 180 positions worth $256M, up 9.2% from $234M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Roberts, Glore & Co withdrew a net $11.9M in Q2 2020, closing 11 positions and reducing 108 holdings. Its most notable exit was RTX Corp, an estimated $1.52M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

Against the trend, Roberts, Glore & Co opened a new position in Vanguard Emerging Markets Government Bond ETF worth $642K.

  • Roberts, Glore & Co's largest Q2 2020 buy was Vanguard Emerging Markets Government Bond ETF: 8,260 shares worth $642K.
  • Roberts, Glore & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $355K increase.
  • Roberts, Glore & Co's biggest Q2 2020 reduction was Microsoft, cutting an estimated $1.77M.
  • Roberts, Glore & Co fully exited RTX Corp in Q2 2020, selling an estimated $1.52M.
  • Roberts, Glore & Co's ten largest holdings make up 33% of its $256M portfolio in Q2 2020.
  • Roberts, Glore & Co opened 20 new positions and closed 11 in Q2 2020.
  • Roberts, Glore & Co's portfolio value rose 9.2% quarter-over-quarter to $256M.

Based on Roberts, Glore & Co's 13F filing for Q2 2020, filed 13 Aug 2020.